Related Experiment Video

Updated: Jun 10, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

An integrated pharmacokinetic-pharmacodynamic model for an Aurora kinase inhibitor

Hiroko Kamei1, Robert C Jackson, Daniella Zheleva

  • 1Division of Mathematics, University of Dundee, Dundee, UK.

Journal of Pharmacokinetics and Pharmacodynamics
|August 10, 2010
PubMed

Insights

A new pharmacokinetic-pharmacodynamic model shows that achieving a critical peak concentration of CYC116 is essential for disrupting chromosome segregation. This model predicts optimal dosing strategies for CYC116, an Aurora kinase inhibitor, in cancer therapy.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Cancer Therapeutics

Background:

  • The spindle assembly checkpoint (SAC) is vital for accurate chromosome segregation during mitosis.
  • Aurora kinases (AKs) are crucial for mitotic progression, making AK inhibitors promising anti-cancer agents.
  • CYC116 is a known inhibitor of Aurora kinases A and B.

Purpose of the Study:

  • To develop an integrated pharmacokinetic-pharmacodynamic (PK-PD) model for CYC116's effects on the SAC.
  • To predict the impact of CYC116 on SAC function in cell culture and mouse models.
  • To explore optimal dosing and scheduling for CYC116 therapy.

Main Methods:

  • Development of an integrated PK-PD model for CYC116.
  • Simulation of cell culture and oral dosing in mice.
  • Analysis of dose, peak concentration, and duration of exposure on SAC function.

Main Results:

  • A critical peak drug concentration of CYC116 is required to induce aberrant kinetochore-microtubule attachments.
  • High total oral doses increase aberrant attachments per cell, while duration above threshold affects the proportion of affected cells.
  • Prometaphase/metaphase duration is a nonlinear function of dose, and efficacy shows saturation.

Conclusions:

  • The PK-PD model provides insights into CYC116's mechanism of action on the SAC.
  • Model predictions can inform the design of future clinical trials for CYC116 and other AK inhibitors.
  • Optimal drug scheduling and dosing are critical for maximizing therapeutic efficacy and minimizing toxicity.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...